Clinical Trial Update: Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma. [Phase 2]

View source ↗

Summary

This open-label, multicenter Phase 2 trial studied CVP chemotherapy followed by an Iodine-131 labeled anti-B1 antibody in previously untreated low-grade non-Hod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Iodine-131 anti-B1 antibody (iodine-131 labeled anti-B1 antibody)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2013-04-25